Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London
Cancer survival 'to double in 10 years' - PressReader
_kevin-harrington-embed.jpg?sfvrsn=70547b69_2 "Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London")
Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Professor Kevin Harrington - YouTube
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program
The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined
Scientists reveal new lines of attack to raise cancer survival rate | Cancer research | The Guardian
Using imaging to predict and improve responses to immunotherapy - Oracle Cancer Trust
Professor Kevin Harrington - The Institute of Cancer Research, London
Cancer: Scientists aim to double survival within a decade | The Independent
Higher Scientific Officer - Targeted Therapy Team, Prof Kevin Harrington (ID496) at The Institute of Cancer Research
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
Scientific Lecture | Kevin Harrington | FRONTAL
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
.jpg?sfvrsn=a729a68_4 "Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London")
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London
